25 May 2023: Clinical Research
Impact of Converting from Immediate-Release Tacrolimus to Envarsus on BK Viremia Incidence in Kidney Transplant Patients with Rapid Metabolism
Graham Towns ABCDEFG* , Gaurav Agarwal ABCDEFG , Ashutosh Tamhane CDE , Clifton Kew AEDOI: 10.12659/MSM.939748
Med Sci Monit 2023; 29:e939748
Figure 1 Incidence of BK viruria and BK viremia. (A) Cumulative incidence of BK viruria as a percentage at 3,6, 9, and 12 months after transplantation in the Envarsus-converted group as compare to the IR-Tac group. (B) Cumulative incidence of BK viremia as a percentage at 3,6, 9, and 12 months after transplantation in the Envarsus-converted group as compared to the IR-Tac group. IR-Tac – Immediate-release tacrolimus